MA43132A - Compositions aqueuses de spironolactone - Google Patents
Compositions aqueuses de spironolactoneInfo
- Publication number
- MA43132A MA43132A MA043132A MA43132A MA43132A MA 43132 A MA43132 A MA 43132A MA 043132 A MA043132 A MA 043132A MA 43132 A MA43132 A MA 43132A MA 43132 A MA43132 A MA 43132A
- Authority
- MA
- Morocco
- Prior art keywords
- spironolactone
- aqueous compositions
- compositions
- aqueous
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical group C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 title 1
- 229960002256 spironolactone Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562495583P | 2015-10-30 | 2015-10-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA43132A true MA43132A (fr) | 2018-09-05 |
Family
ID=58630885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA043132A MA43132A (fr) | 2015-10-30 | 2016-10-28 | Compositions aqueuses de spironolactone |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9757394B2 (fr) |
| EP (1) | EP3368045A4 (fr) |
| CA (1) | CA3003028A1 (fr) |
| MA (1) | MA43132A (fr) |
| WO (1) | WO2017075463A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10493083B2 (en) * | 2015-10-30 | 2019-12-03 | Cmp Development Llc | Spironolactone aqueous compositions |
| US12053447B2 (en) | 2019-06-25 | 2024-08-06 | NuBioPharma, LLC | Oral solution and powder to liquid compositions of balsalazide |
| WO2022074528A1 (fr) * | 2020-10-06 | 2022-04-14 | Callidus Research Laboratories Limited | Solution orale stable de spironolactone |
| CN118632687A (zh) * | 2021-11-11 | 2024-09-10 | 阿尔库缇斯生物疗法股份有限公司 | 用于深层皮肤药物递送的螺内酯药物组合物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4837211A (en) | 1987-04-06 | 1989-06-06 | Carolina Medical Products, Inc. | Spironolactone composition |
| GB0114532D0 (en) * | 2001-06-14 | 2001-08-08 | Jagotec Ag | Novel compositions |
| WO2003004009A1 (fr) * | 2001-07-02 | 2003-01-16 | Geneva Pharmaceuticals, Inc. | Formulation a compression directe de medicaments faiblement compressibles tels que le chlorhydrate de metformine |
| US7300670B2 (en) | 2002-04-03 | 2007-11-27 | Unilab Pharmatech, Ltd. | Oral suspension formulation |
| EP1492511B3 (fr) * | 2002-04-09 | 2012-05-02 | Flamel Technologies | Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s) |
| GB2395124A (en) * | 2002-11-16 | 2004-05-19 | Fluid Technologies Plc | Palatable microcapsules |
| JP2006511525A (ja) | 2002-12-13 | 2006-04-06 | ヤゴテック アーゲー | ナノ粒子状スピロノラクトン局所製剤 |
| US20080069779A1 (en) * | 2003-08-04 | 2008-03-20 | Foamix Ltd. | Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof |
| WO2007086078A2 (fr) * | 2006-01-30 | 2007-08-02 | Panacea Biotec Ltd. | Compositions pharmaceutiques atypiques et processus de preparation correspondant |
| US9585836B2 (en) * | 2008-06-05 | 2017-03-07 | Peter Quagliano | Palatable liquid dilution vehicles for oral contrast agents |
| US20130039871A1 (en) * | 2010-04-27 | 2013-02-14 | Kao Corporation | Aqueous composition contained in container |
| US9737609B2 (en) * | 2014-08-20 | 2017-08-22 | Professional Compounding Centers Of America (Pcca) | Natural suspending agent including a synergistic blend of xanthan gum and konjac powder for oral pharmaceutical suspensions |
-
2016
- 2016-10-28 WO PCT/US2016/059483 patent/WO2017075463A1/fr not_active Ceased
- 2016-10-28 US US15/337,559 patent/US9757394B2/en active Active
- 2016-10-28 CA CA3003028A patent/CA3003028A1/fr not_active Abandoned
- 2016-10-28 EP EP16860950.1A patent/EP3368045A4/fr not_active Withdrawn
- 2016-10-28 MA MA043132A patent/MA43132A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3368045A1 (fr) | 2018-09-05 |
| WO2017075463A1 (fr) | 2017-05-04 |
| CA3003028A1 (fr) | 2017-05-04 |
| EP3368045A4 (fr) | 2019-08-07 |
| US20170119796A1 (en) | 2017-05-04 |
| US9757394B2 (en) | 2017-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3297455A4 (fr) | Compositions de glycoside | |
| DK3361870T3 (da) | Fungicidsammensætninger | |
| PT3355990T (pt) | Compostos semifluorados e as suas composições | |
| HUE049233T2 (hu) | C9ORF72-expresszió módosítására szolgáló készítmények | |
| DK3099775T3 (da) | Vandige detergentsammensætninger | |
| EP3476002C0 (fr) | Compositions aqueuses d'encre | |
| EP3289026A4 (fr) | Composition aqueuse de revêtement antitache | |
| EP4218939C0 (fr) | Compositions d'encre | |
| EP3334726A4 (fr) | Compositions de plinabuline | |
| DK3250182T3 (da) | Dispergible sammensætninger | |
| PT3457851T (pt) | Derivados de sobetiroma | |
| DK3253485T3 (da) | No-holdige sammensætninger | |
| EP3337340A4 (fr) | Solutions de glycoside de stéviol | |
| DK3283210T3 (da) | Fremgangsmåde | |
| EP3388505A4 (fr) | Composition de tensio-actif | |
| EP3388504A4 (fr) | Composition de tensio-actif | |
| FR3023290B1 (fr) | Derives de flavaglines | |
| EP3328991A4 (fr) | Biosynthèse de polycétides | |
| LT3216451T (lt) | Oftalmologinė vandeninė kompozicija | |
| EP3397352A4 (fr) | Compositions de déodorant | |
| EP3277701A4 (fr) | Synthèse de désosamines | |
| DK3316857T3 (da) | Multifasiske sammensætninger | |
| PL3528791T3 (pl) | Kompozycje dyspergowalne | |
| MA43132A (fr) | Compositions aqueuses de spironolactone | |
| IL272670A (en) | Preparation of micro-electrodes |